01873 VIVA BIOTECH
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 1.67X | Oper Margin | 17.6% |
---|---|---|---|
LT Debt/Equity | 19.2% | Net Margin | 8.4% |
Total Debt/Equity | 33.8% | Return on Equity | 4.4% |
Price/Book | 1.48X | Return on Assets | 2.4% |
(HKD 2.800) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | 177.92 | -127.98 | -592.53 | 351.70 | -459.15 |
---|---|---|---|---|---|
Net Profit Growth (%) | +239.0 | +78.4 | -268.5 | +176.6 | -254.5 |
Earnings Per Share (HKD) | 0.083 | -0.066 | -0.309 | 0.184 | -0.292 |
Earnings Per Share Growth (%) | +226.2 | +78.7 | -268.1 | +163.0 | -237.7 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | 0.027 |
P/E* (X) | 33.61 | N/A | N/A | 15.22 | N/A |
Yield (%) | N/A | N/A | N/A | N/A | 0.96 |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 1.896 | 1.881 | 2.089 | 2.474 | 2.325 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified # | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
(RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 831.874 | 981.824 | -15.3 | 1,142 |
Operating Result | 172.113 | 185.516 | -7.2 | 36.752 |
Associates | -0.418 | 0 | N/A | 0 |
Profit Before Taxation | 171.695 | 185.516 | -7.5 | 36.752 |
Taxation | 23.058 | 41.279 | -44.1 | 23.093 |
Profit /( Loss) After Taxation | 148.637 | 144.237 | +3.1 | 13.659 |
Minority Interests | 26.832 | 27.429 | -2.2 | 12.646 |
Net Profit | 121.805 | 116.808 | +4.3 | 1.013 |
Earnings Per Share () | 0.0632 | 0.0586 | +7.8 | 0.0006 |
Announcement Date | 2025-08-28 | 2024-08-29 | NA | 2023-08-29 |
* Annualised
Last Update Time: 2025-09-08 21:40:25